Les mucorégulateurs dans les syndromes bronchiques aigus : point sur les pratiques en médecine générale et les données de la littérature

Therapies - Tập 58 - Trang 519-524 - 2003
Nicolas Roche1, Bernard Lebeau2, Jean-Claude Pujet3, Gérard Lenoir4, François Liard5, Karim Keddad6
1Service de Pneumologie, Hôpital Hôtel-Dieu, Paris, France
2Service de pneumologie, hôpital Saint-Antoine, Paris, France
3Centre de Traitement des Affections Respiratoires (C.T.A.R.), Paris, France
4Service de Pédiatrie, Hôpital Necker Enfants Malades, Paris, France
5Cabinet Médical, Saint-Epain, France
6Affaires Médicales, Aventis Pharma/Théraplix, Paris, France

Tài liệu tham khảo

Le Fur, 1995, Bronchopneumopathies aiguës et antibiothérapie en 1992 : aspects médico-économiques Carré, 1991, Bronchites aiguës : éditions techniques, Encycl Méd Chir (Paris-France) Pneumologie, 6003, B10 Smyrnios, 1998, From a prospective study of chronic cough: diagnostic and therapeutic aspects in older adults, Arch Intern Med, 158, 1222, 10.1001/archinte.158.11.1222 French, 1998, Impact of chronic cough on quality of life, Arch Intern Med, 158, 1657, 10.1001/archinte.158.15.1657 French, 1992, A quality-of-life method for estimating the value of avoided morbidity, Am J Public Health, 82, 1553, 10.2105/AJPH.82.11.1553 Vergnenegre, 1995, Retentissement sur la qualité de vie des symptômes respiratoires et de l’obstruction des voies aériennes dans une population agricole, Rev Mal Respir, 12, 615 Gonzales, 1997, Antibiotic prescribing for adults with colds, upper respiratory tract infections and bronchitis by ambulatory care physicians, JAMA, 278, 901, 10.1001/jama.1997.03550110039033 Nyquist, 1998, Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis, JAMA, 279, 875, 10.1001/jama.279.11.875 Huchon, 1996, Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey, Eur Respir J, 9, 1590, 10.1183/09031936.96.09081590 1999, Agence du médicament. Prescription et consommation des antibiotiques en ambulatoire, Presse Med, 28, 343 Arroll, 2001, Antibiotics for acute bronchitis, BMJ, 322, 939, 10.1136/bmj.322.7292.939 Anthonisen, 1987, Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease, Ann Intern Med, 106, 196, 10.7326/0003-4819-106-2-196 Guillemot, 1998, Low dosage and lung treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae, JAMA, 279, 365, 10.1001/jama.279.5.365 SPILF, 2000, Med Mal Infect, 30, 568, 10.1016/S0399-077X(00)80024-4 Braga, 1984, Evaluation of the elastic and viscous components of bronchial mucus before and after S-carboxymethylcysteine-Lys treatment, Int J Clin Pharmacol Res, 4, 121 Braga, 1990, Long-lasting effects on rheology and clearance of bronchial mucus after short-term administration of high doses of carbocysteine-lysine to patients with chronic bronchitis, Respiration, 57, 353, 10.1159/000195871 Edwards, 1976, S-carboxymethylcysteine in the fluidification of sputum and treatment of chronic airway obstruction, Chest, 70, 506, 10.1378/chest.70.4.506 Todisco, 1985, Effect of N-acetylcysteine in subjects with slow pulmonary mucociliary clearance, Eur J Respir Dis Suppl, 139, 136 Olivieri, 1985, Improvement of mucociliary transport in smokers by mucolytics, Eur J Respir Dis Suppl, 139, 142 Olivieri, 1991, Activity of erdosteine on mucociliary transport in patients affected by chronic bronchitis, Respiration, 58, 91, 10.1159/000195904 Zheng, 1999, The effects of S-carboxymethylcysteine and N-acetylcysteine on the adherence of Moraxella catarrhalis to human pharyngeal epithelial cells, Microbiol Immunol, 43, 107, 10.1111/j.1348-0421.1999.tb02381.x Braga, 1999, Effect of erdosteine and its metabolites on bacterial adhesiveness, Arzneimittelforschung, 49, 344 Riise, 1994, The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy?, Eur Respir J, 7, 94, 10.1183/09031936.94.07010094 Biscatti, 1972, Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics [Italian], Minerva Pediatr, 24, 1075 Malka, 1990, Intérêt d’un mucolytique, la carbocistéine, dans la bronchite aiguë de l’enfant, Med Infant, 8, 687 Nakayama, 1977, Clinical effect of SCMC in pediatric field, Jap Jal Red, 30, 1823 Zanini, 1994, Il lisomucil in campo pediatrico, Clin Eur, 13, 1 Titti, 2000, A controlled multicenter pediatric study in the treatment of acute respiratory tract disease with the aid of a new specific compound, erdosteine: IPSE, Italian Pediatric Study Erdosteine, Int J Clin Pharmacol Ther, 38, 402, 10.5414/CPP38402 Brocard, 1980, Etude multicentrique en double aveugle avec acétylcystéine oral vs. placebo, Eur J Respir Dis Suppl, 111, 65 Roa, 1995, Clinical effectiveness of a combination of bromhexine and amoxicillin in lower respiratory tract infection: a randomized controlled trial, Arzneimittelforschung, 45, 267 Verstraeten, 1979, Mucolytic treatment in chronic obstructive pulmonary disease: double-blind comparative clinical trial with N-acetylcysteine, bromhexine and placebo, Acta Tuberc Pneumol Belg, 70, 71 Olivieri, 1991, Role of bromhexine in exacerbations of bronchiectasis: double blind randomized multicenter study versus placebo, Respiration, 58, 117, 10.1159/000195910 Germouty, 1987, Clinical efficacy of ambroxol in the treatment of bronchial stasis: clinical trial in 120 patients at two different doses, Respiration, 51, 37, 10.1159/000195273 Marchioni, 1995, Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment: ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study, Int J Clin Pharmacol Ther, 33, 612 Puchelle, 1978, Effect of the mucoregulator S-carboxy-methyl-cysteine in patients with chronic bronchitis, Eur J Clin Pharmacol, 14, 177, 10.1007/BF02089957 Ericsson, 1987, Ambroxol and simple chronic bronchitis: effects on subjective symptoms and ventilatory function, Respiration, 51, 33, 10.1159/000195272 Aubier, 1999, Etude multicentrique, contrôlée, en double aveugle, de l’efficacité et de la tolérance de Vectrine (erdostéine) versus placebo dans le traitement de la bronchite chronique hypersécrétante stabilisée, Rev Mal Respir, 16, 521 Allegra, 1996, Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial, Respiration, 63, 174, 10.1159/000196540 Grillage, 1985, Long-term oral carbocisteine therapy in patients with chronic bronchitis: a double blind trial with placebo control, Br J Clin Pract, 39, 395, 10.1111/j.1742-1241.1985.tb07868.x